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Isl1 is a LIM homeobox transcription factor showing conserved expression in the developing and mature
vertebrate pancreas. So far, functions of pancreatic Isl1 have mainly been studied in the mouse, where Isl1
has independent functions during formation of exocrine and endocrine tissues. Here, we take advantage
of a recently described isl1 mutation in zebraﬁsh to address pancreatic isl1 functions in a non-
mammalian system. Isl1 in zebraﬁsh, as in mouse, shows transient expression in mesenchyme ﬂanking
the pancreatic endoderm, and continuous expression in all endocrine cells. In isl1 mutants, endocrine
cells are speciﬁed in normal numbers but more than half of these cells fail to establish expression of
endocrine hormones. By using a lineage tracking approach that highlights cells leaving cell cycle early in
development, we show that isl1 functions are different in ﬁrst and second wave endocrine cells. In isl1
mutants, early forming ﬁrst wave cells show virtually no glucagon expression and a reduced number of
cells expressing insulin and somatostatin, while in the later born second wave cells somatostatin
expressing cells are strongly reduced and insulin and glucagon positive cells form in normal numbers.
Isl1 mutant zebraﬁsh also display a smaller exocrine pancreas. We ﬁnd that isl1 expression in the
pancreatic mesenchyme overlaps with that of the related genes isl2a and isl2b and that pancreatic
expression of isl-genes is independent of each other. As a combined block of two or three isl1/2 genes
results in a dose-dependent reduction of exocrine tissue, our data suggest that all three genes
cooperatively contribute to non-cell autonomous exocrine pancreas extension. The normal expression
of the pancreas mesenchyme markers meis3, fgf10 and fgf24 in isl1/2 depleted embryos suggests that this
activity is independent of isl-gene function in pancreatic mesenchyme formation as was found in mouse.
This indicates species-speciﬁc differences in the requirement for isl-genes in pancreatic mesenchyme
formation. Overall, our data reveal a novel interaction of isl1 and isl2 genes in exocrine pancreas
expansion and cell type speciﬁc requirements during endocrine cell maturation.
& 2013 Elsevier Inc. Open access under CC BY-NC-ND license.Introduction
The pancreas is a vertebrate-speciﬁc endodermal organ with
essential functions in food digestion and glucose homeostasis. The
mature organ is composed of an exocrine compartment with
acinar and duct cells that produce and transport digestive
enzymes into the gut, and an endocrine compartment from which
metabolism-regulating peptide hormones are secreted into the
blood stream. In higher vertebrates, endocrine cells are arranged
in small clusters termed islets (islet of Langerhans in mammals)
that contain up to ﬁve cells types each expressing a speciﬁc
hormone: α-, β-, δ-, ε- and PP cells expressing glucagon (gcg),
insulin (ins), somatostatin (sst), ghrelin and pancreatic polypeptideilﬁnger),
c.at (D. Meyer).
-ND license.(pp), respectively. Formation of the pancreas can be formally
divided into two phases termed primary and secondary transition.
In amniotes, primary transition refers to the outgrowth of epithe-
lial buds of dorsal and ventral foregut endoderm into the
surrounding pancreatic mesenchyme demarcating the onset of
pancreas morphogenesis. During this process, a population of
postmitotic endocrine cells of unknown function, also termed
‘ﬁrst wave’ cells, is established. Secondary transition deﬁnes the
subsequent massive proliferation and expansion of the pancreatic
buds and the accompanying differentiation of exocrine and ‘sec-
ond wave’ endocrine cells from which the organ is ﬁnally formed
(Pan and Wright, 2011).
Genetic studies have been extremely successful in deﬁning the
importance of speciﬁc signaling pathways and transcription fac-
tors in regulating pancreas development. While the mouse has
been the major model for such studies, more recently the zebraﬁsh
had gained attention as a model that is readily amenable
to genetic and in vivo imaging approaches (Field et al., 2003;
A. Wilﬁnger et al. / Developmental Biology 378 (2013) 25–3726Kimmel and Meyer, 2010; Kinkel and Prince, 2009; Tiso et al.,
2009). Importantly, pancreas in mouse and ﬁsh has a conserved
physiological function, a very similar cellular architecture, and
conserved expression and function of most developmental genes
(Eames et al., 2010; Jurczyk et al., 2011; Yee et al., 2005). Despite
these similarities, studies in ﬁsh also revealed some evolutionary
differences between mammalian and ﬁsh pancreas development.
Pancreas development in zebraﬁsh is morphologically visible at
24 h post fertilization (24 hpf) by the formation of an endocrine
cluster of 50–60 cells that are located dorsal to the gut endoderm
(Biemar et al., 2001; Kimmel and Meyer, 2010). This early islet
separates from the endoderm and by 48 hpf becomes encircled by
a second endodermal protrusion. Based on their position and by
analogy to the buds formed during primary transition in mouse,
the early islet and the later forming protrusion in zebraﬁsh have
been termed dorsal and ventral bud, respectively (Field et al.,
2003). However, the fates of these buds are different in mouse and
ﬁsh. In mouse, the dorsal and ventral bud both contributes to ﬁrst
and second wave endocrine, as well as to exocrine cells (Pan and
Wright, 2011). By contrast, zebraﬁsh dorsal bud consists exclu-
sively of ﬁrst wave endocrine cells (dorsal bud derived cells, DBCs),
while the ventral bud gives rise to second wave endocrine (here-
after termed ventral bud derived cells, VBCs), exocrine and duct
cells, and thus to all cells forming the mature pancreas (Field et al.,
2003; Hesselson et al., 2009; Wang et al., 2011). Further, ﬁrst wave
cells in mouse mainly express Gcg, while in ﬁsh, at least 4 early
endocrine cell types, expressing Gcg (α-cells), Ins (β-cells), Sst
(δ-cells) and Ghrelin (ε-cells) can be distinguished (Hesselson
et al., 2009; Pan and Wright, 2011; Tiso et al., 2009).
Correlating with these differences, the molecular control
underlying formation of the two pancreatic buds appears slightly
different in mouse and ﬁsh. Differences were found for example
for the role of the homeobox transcription factors Pdx1 and Mnx1/
Hb9, that both show a conserved expression in pre-pancreatic
endoderm and later in differentiating β-cells. In mouse knock-out
studies the two phases of expression were shown to be required
for early pancreas morphogenesis and for β-cell maturation
(Harrison et al., 1999; Larsson et al., 1996; Li and Edlund, 2001;
Ofﬁeld et al., 1996; Pan and Wright, 2011). By contrast,
morpholino-based (MO) knockdown studies of these genes in ﬁsh
revealed no major defects in early pancreas morphology but did
provide evidence for a conserved function in specifying second
wave endocrine cells (pdx1) and β-cell maturation (hb9) (Kimmel
et al., 2011). These data revealed differences mainly in the
regulation of early pancreas morphogenesis and in ﬁrst wave
endocrine speciﬁcation in ﬁsh and mouse. Formation of second
wave endocrine cells appears to be more similar in ﬁsh and mouse,
even though not that much is known about these processes in
zebraﬁsh.
In this study, we focus on the LIM-Homeodomain (LIM-HD)
transcription factor isl1 (Insulin gene enhancer protein 1) which in
mouse has been shown to be required for early pancreas morpho-
genesis and endocrine differentiation (Ahlgren et al., 1997; Du
et al., 2009; Liu et al., 2011, 2012; May, 2010). While initially
identiﬁed as a direct regulator of insulin expression in RIN 14B
endocrine cells (Karlsson et al., 1990), isl1 in zebraﬁsh shows
evolutionary conserved expression in pancreatic mesenchyme
during embryogenesis and in endocrine cells of the embryonic
and adult pancreas, including ﬁrst wave endocrine cells (Manfroid
et al., 2007). Mesenchymal isl1 expression is limited to the initial
stages of pancreas development. In mouse, this expression is
restricted to the cells ﬂanking the dorsal pancreatic endoderm
(Ahlgren et al., 1997), while in ﬁsh expression is found in the
vicinity of the late forming ventral bud. Knock-out analyses in
the mouse revealed that the distinct expression domains in
mesenchyme and endoderm are independently required to induceformation of the dorsal pancreatic bud and pancreatic mesench-
yme and to initiate endocrine hormone expression, respectively.
Due to the lethality of the Isl1 mutant shortly after onset of
pancreas morphogenesis, analyses of later pancreatic fates could
only be done in organ culture. It was found that wild type but not
Isl1 mutant pancreatic mesenchyme is able to induce differentia-
tion of exocrine tissue in co-cultured mutant dorsal endoderm,
demonstrating a non-cell autonomous function of mesenchymal
Isl1 in inducing exocrine pancreas (Ahlgren et al., 1997).
More recently, a conditional knock-out approach has been used
to address Isl1 functions in second wave endocrine cells. Based on
a Pdx1-Cre driven knock-out strategy, it was possible to efﬁciently
remove endodermal Isl1 expression shortly after onset of second-
ary transition (Du et al., 2009; Liu et al., 2011). In these mutants,
expression of the endocrine progenitor marker Pax6 was initiated
in normal numbers but unlike in the control embryos, only a few
of these Pax6 positive cells established expression of the hor-
mones Gcg, Ins, Sst and PP. During later development, the mutants
displayed a reduced number of Pax6 expressing endocrine cells
and this reduction was accompanied by a decreased rate of β-cell
proliferation and an increased rate of apoptosis within the pan-
creatic islet (Du et al., 2009). Furthermore, a transgenic increase of
Isl1 expression was shown to enhance glucose-induced insulin
secretion (Liu et al., 2012). The mouse data reveal requirements for
Isl1 during induction of exocrine tissue and for the expansion,
maturation and physiological responses in endocrine cells. More-
over, molecular approaches provided ﬁrst hints for the molecular
targets and interaction partners of Isl1. MafA and Arx, two genes
playing fundamental roles in the process of β- and α-cell differ-
entiation, have been found as direct transcriptional targets of
mouse Isl1 (Du et al., 2009; Liu et al., 2011). In vitro studies also
identiﬁed Isl1 as a direct regulator of c-Myc and Cyclin D1,
providing a possible link between Isl1 function and regulation of
islet-cell proliferation (Guo et al., 2011). Most recently, the Lim-
domain-binding coregulator Ldb1 was shown to be a critical
cofactor for Isl1-dependent expression of MafA, Arx, ins and Glp1r,
which encodes an important regulator of Ins synthesis and release
(Hunter et al., 2013).
Though pancreatic expression of Isl1 is highly conserved, its
functions have not been analyzed in any model system besides the
mouse. In order to study pancreatic isl1 functions in a non-
mammalian system, we make use of a recently described isl1
TILLING mutant in zebraﬁsh. In these ﬁsh, an A to T transition
creates a premature stop codon at amino acid 88 leading to a
complete loss of the homeodomain (de Pater et al., 2009). Mutants
are viable until late embryogenesis and therefore enable studies
on isl1 function during both early and later stages of pancreas
development. In contrast to mouse, we ﬁnd that isl1 in zebraﬁsh is
not essential for pancreatic mesenchyme formation or for the
formation of hormone-expressing ﬁrst wave endocrine cells. We
show that isl1 has overlapping function with isl2a and isl2b in
pancreatic mesenchyme in promoting expansion of the exocrine
pancreas. We also show that isl1 alone has cell type speciﬁc
functions in endocrine cell maturation, and that these functions
are different in ﬁrst and second wave endocrine cells. The data
reveal isl1 functions that are unexpected when considering the
mouse data, and show a major difference in the molecular
regulation of ﬁrst and second wave cells in zebraﬁsh.Materials and methods
Zebraﬁsh maintenance and ﬁsh lines
Zebraﬁsh (danio rerio) were maintained according to standard
protocols. Developing embryos were staged by hours post fertilization
A. Wilﬁnger et al. / Developmental Biology 378 (2013) 25–37 27(hpf) when incubated at 28 1C (Kimmel et al., 1995). Embryos older
than 24 hpf were treated with 0.2 mM PTU to prevent pigmentation.
isl1sa0029þ /− ﬁsh (de Pater et al., 2009) were obtained from the Sanger
Institute (Cambridge/UK). Homozygous isl1 mutant embryos were
identiﬁed either based on the absence of a touch response (at
24 hpf) or by the lack of GFP labeled motoaxons in tg[hb9:GFP]ml2
transgenic background (Arkhipova et al., 2012; Flanagan-Steet et al.,
2005). tgBAC[NeuroD:EGFP]nl1 ﬁsh were obtained from Teresa Nicolson
(Obholzer et al., 2008). Fixed homozygous cloche mutants (Stainier
et al., 1995) and control littermates were obtained from Arndt
Siekmann.
Whole-mount in situ hybridization
In situ hydridization was performed with digoxigenin labeled
antisense RNA probes (DIG RNA Labeling Mix, Roche) and α-
Digoxigenin-AP antibody (1:4000, Roche) using previously pub-
lished protocols (Hauptmann and Gerster, 2000). Antisense RNA
probes were generated after linearizing the corresponding plas-
mids and using T7 or Sp6 RNA Polymerase. The following probes
were used: isl1 (Gong et al., 1995), isl2a (Gong et al., 1995), isl2b
(gift from Hitoshi Okamoto) (Kikuchi et al., 1997; Tokumoto et al.,
1995), insulin, glucagon, somatostatin, ghrelin (all kindly provided
by Francesco Argenton) (Argenton et al., 1999; Biemar et al., 2001),
pax6b, meis3, fgf10, fgf24, arx (gifts from Bernard Peers) (Fischer
et al., 2003; Manfroid et al., 2007; Miura et al., 1997; Puschel et al.,
1992; Sagerstrom et al., 2001).
Immunoﬂuorescence
Embryos were ﬁxed for 90 min at room temperature in 4% PFA,
1% DMSO. After ﬁxation, the embryos were washed 35 min in 1x
PBS, 0.1% Tween 20, the yolk was removed and embryos were
incubated in blocking buffer containing 1% DMSO, 1% sheep serum,
1% BSA and 1% Triton X-100 in 1x PBS for at least 60 min at room
temperature. The embryos were then incubated overnight at þ4 1C
with primary and secondary antibodies, at 1:200 and 1:1000
dilutions, respectively. Primary antibodies: polyclonal guinea pig
anti-insulin (Dako; A0564), polyclonal rabbit anti-human glucagon
(Dako; A0565), polyclonal rabbit anti-somatostatin (Dako; A0566),
anti-Islet-1 & 2 homeobox (mouse, 39.4D5; DSHB) and monoclonal
mouse IgG anti-GFP (Roche, Cat. no. 11814460001). Secondary
antibodies: Alexa Fluor 488 goat anti-mouse IgG (Invitrogen;
A-11029), Alexa Fluor 555 goat anti-guinea pig IgG (Invitrogen;
A-21435), Alexa Fluor 546 goat anti-rabbit IgG (Invitrogen, A-
11035), Alexa Fluor 633 goat anti-rabbit IgG (Invitrogen; A-21070),
Alexa Fluor 633 goat anti-guinea pig IgG (Invitrogen; A-21105), and
mouse Goat IgG, Cy3-conjugated (Chemicon; AP124C).
Morpholino and mRNA Injections
For knockdown of isl2a and isl2b, embryos were injected with a




H2B-mRFP1 encoding mRNA was produced from NotI linearized
p13-pCS-H2B-mRFP1 (kindly provided by S.G. Megason) using Sp6
RNA Polymerase and mMessageMachine (Ambion). For injection,
the H2B-mRFP1 mRNAwas diluted to 60 ng/ml. Eggs were collected
shortly after fertilization, transferred to injection ramps and
injected with 1–3 nl of mRNA solution before they reached the
2-cell stage. 6 h after injection, RFPþ eggs were sorted out and
kept at 28 1C in the dark until the embryos were ﬁxed for further
analyses.TUNEL staining
Embryos were ﬁxed for 1 h at room temperature in 4% PFA,
1% DMSO. The yolk was removed and embryos were permeabi-
lized by incubation in 1x PBS, 0.3% Triton X-100 for 20 min at room
temperature. After Proteinase K digestion (10 mg/ml) and re-
ﬁxation in 4% PFA for 20 min at room temperature, the staining
was performed using the In situ Cell Death Detection Kit, TMR
red (Roche, Cat. no. 12156792910) according to manufactors
instructions.
EdU staining
For EdU based detection of proliferating cells, the Click-IT 647
Kit (Invitrogen C10085) was used. At 48 hpf, 5 nl EdU solution
(50 μM EdU/2% DMSO) was injected into the yolk and common
cardinal vein (Kramer-Zucker et al., 2005) of PTU-treated embryos
anaesthesyed with 0.6 mM tricaine. Injected ﬁsh were successively
incubated in 50 mM EdU/0.4% DMSO and kept in the dark up to
96 hpf. Samples were ﬁxed in 4% PFA/1% DMSO for 2 h at room
temperature (RT), washed in 1x PBST and deyolked. EdU staining
was performed as previously described (Hesselson et al., 2009).
qPCR
Total RNA samples were prepared from pools of 15–20 embryos
at the stages indicated and from pools of 25–30 manually
dissected embryonic pancreata of 4 dpf tg[hb9:GFP]ml2 embryos
using Trizol Reagent (Ambion). cDNA was prepared using the First
Strand cDNA Synthesis Kit #K1641 (Thermo Scientiﬁc). HOT Fire-
Pol EvaGreen qPCR Mix Plus (Solis BioDyne, Cat.No. 08-24-00020)
was used for qPCR reactions in a CFX Connect Real-Time System
(Bio Rad). Reactions were performed on two biological samples
with two technical replicates each. Primers were designed using
the Software “QuantPrime” (Arvidsson et al., 2008) and are listed
in the supplementary information (Table. S7).
Microscopy
Confocal images were generated as previously described
(Arkhipova et al., 2012) with a Zeiss LSM Exciter5 microscope
equipped with the following lasers: 25 mW Argon laser (468, 488
and 514 nm), 1 mW 543 nm HeNe-laser, 5 mW 633 nm HeNe-laser
and a 25 mW 405 nm diode-laser. Fluorescence detection was
performed with the following ﬁlters: BP 505–530 (GFP and Alexa
488), LP 560 (Cy3, Alexa 555) and LP 650 (Alexa 633, Click-IT 647). A
Leica DM 6000 microscope and Leica DFC300 FX camera was used
for DIC images of whole mount in situ staining. Phenotypes of isl1
mutant embryos were captured on a Leica MZ16A stereomicroscope
using a Leica DFC320 camera. Adobe Photoshop CS3 was used for
image arrangement and adjustment.
Statistics
Statistical analysis was performed by GraphPad Prism 5
(GraphPad Software, La Jolla, CA, USA) using 1-way ANOVA and
Tukey–Kramer Test (Figs. 1, 5I, 7G, 8 and S3) or unpaired t-test
(Figs. 4, 7H & S3). For qPCR data, unpaired t-test (Fig. 1) and 1-way
ANOVA with Bonferroni's Multiple Comparison Test (Figs. 2 and 5)
was used. P-values for statistical signiﬁcance are shown in each
ﬁgure. All graphs show Meanþstandard error (SEM).
Measuring of exocrine pancreas
The length of the exocrine pancreas was measured from head
to tail of trypsin stained embryos. Images were taken using a 10x
Fig. 1. Reduced expression of endocrine hormones in isl1 mutants. (A–F) Confocal image projections of the pancreatic islet in control (A–C) and isl1−/− embryos (D–F) that
were co-immunostained for Ins (green) and Sst (red) at 28 hpf (A, D), 48 hpf (B, E) and 76 hpf (C, F). (G–L) Immunostainings for Gcg (purple) in control (G–I) and in isl1−/−
embryos (J–L) at 48 hpf (G, J), 76 hpf (H, K) and 96 hpf (I, L). All embryos are shown from ventral with the anterior to the left. (M) Quantitative analysis of hormone expressing
cells in control and isl1−/− embryos. Bars show meanþSEM. (N) Relative expression levels of ins, gcga and sst2mRNA in isl1−/−mutant ﬁsh in relation to control littermates as
revealed by qPCR analyses of whole embryo RNA preparations, normalized to EF1α.
A. Wilﬁnger et al. / Developmental Biology 378 (2013) 25–3728Ph1 Objective and a Leica DM6000 microscope. The longest
possible distance from the head to the tail of the exocrine pancreas
was measured using the Fiji plugin “Scale Bar tools for micro-
scope” by Gilles Carpentier (Carpentier G. Contribution: Scale Bar
Tools for Microscop ImageJ News, 4 June 2009).Results
isl1 is required for proper formation of α-, β- and δ-cells
Previous analyses of the zebraﬁsh TILLING mutation isl1sa0029
(de Pater et al., 2009) showed that homozygous mutant ﬁsh,
unlike the Isl1 mouse mutants, are viable until late embryogenesis
(see also Fig. S1). Taking advantage of the long survival we asked if
isl1 has an evolutionary conserved requirement during pancreas
formation. Immunostainings with antibodies against endocrine
hormones at 28 hpf, 48 hpf and 76 hpf revealed a reduction of
more than 50% in the number of Ins and Sst expressing cells in the
mutants compared to phenotypic control littermates (Fig. 1A, F andM). An even more dramatic reduction was found for the number of
Gcgþ cells, which were virtually absent in mutant embryos at 48
hpf and only very few Gcgþ cells could be detected at 72 hpf and
96 hpf (Fig. 1G, M, and Table. S1). The reduced number of
endocrine hormone expressing cells in isl1mutants was conﬁrmed
by whole-mount in situ hybridization analyses for ins and sst2 at
24 hpf, 48 hpf and 72 hpf (Fig. S2A–L) and for gcga at 52 hpf,
72 hpf and 96 hpf (Fig. S2M–R). Notably, control and isl1 mutant
embryos both showed 1–2 ghre mRNA positive cells per embryo
suggesting that ε-cell formation is not affected in isl1 mutants
(data not shown). Quantitative RT-PCR (qPCR) analyses on mRNA
from 28 hpf and 96 hpf embryos further conﬁrmed reduced
expression of ins (11%72% at 28 hpf, 32%73% at 96 hpf), sst2
(19%72% at 28 hpf, 41%72% at 96 hpf) and gcga mRNA (52%76%
at 28 hpf, 62%715% at 96 hpf). The robust decrease of ins and sst2
at 28 hpf suggests that in mutants, hormone expressing cells are
not only reduced in number but in addition express lower
concentrations of ins and sst2 mRNA. In summary, these data
reveal a conserved requirement of isl1 for α-, β- and δ-cell
formation.
Fig. 2. Unchanged expression of early endocrine markers in isl1mutants. Whole mount in situ hybridizations for isl1 (A–F) and pax6b (G–J) mRNA in control (A, C, E, G, I) and
in isl1−/− embryos (B, D, F, H, J) at 24 hpf (A, B, G, H), 48 hpf (C, D) and 76 hpf (E, F, I, J). Note that the pattern and intensity of isl1 signals in the pancreatic mesenchyme (black
arrow head) and in the endocrine islet (white arrow head) is indistinguishable in control and mutant embryos. Embryos are shown from ventral with anterior to the left.
(K–P) Whole mount in situ hybridizations for arx. (K, N) Dorsal view of control embryos at 24 hpf (K) and 48 hpf (N). Insets mark the position of the pancreatic area shown in
higher magniﬁcation panels (L M, O, P). Images show a ventral view of control (L, O) and isl1−/− mutant (M, P) embryos. (Q) qPCR analysis for hormone and transcription
factor encoding mRNA of isolated pancreata from 96 hpf old embryos. Shown are relative expression levels in pancreata of mutant as compared to control embryos,
normalized to the relative expression levels of ins obtained for 96 hpf whole embryonic mRNA.
Fig. 3. \Pancreatic expression of isl1, isl2a and isl2b. Comparison of isl1 (A–E), isl2a (F–J) and isl2bmRNA (K–O) expression at 24 hpf (B, C, G, H, L, M) and 48 hpf (A, D–F, I–K, N, O).
Embryos are shown from the dorsal (A, F, K) or ventral view (rest). Insets shown in the overview images (A, F, K) indicate the relative position of the higher resolution images shown
on the right side. The mRNA stains were performed in tg[neuroD:GFP] embryos in which immunoﬂuorescence detection of GFP (green signals in C, E, H, J, M, O) was used to
highlight endocrine cells (arrows mark the position of the pancreatic islet). Note that only isl1 signals overlap with GFP. Expression of isl2a is found in the mesenchyme anterior the
endocrine cells at 24 hpf and left of the GFP labeled endocrine cells at 48 hpf in a pattern overlapping with that of the mesenchymal isl1 expression (arrowheads mark similar
position in all embryos). Signals for isl2b are also found anterior to the endocrine cells at 24 hpf (arrowhead) and in a broader mesenchymal domain directly adjacent to the GFP
signals at 48 hpf.
A. Wilﬁnger et al. / Developmental Biology 378 (2013) 25–37 29
Fig. 4. isl2a does not contribute to endocrine cell formation. (A–C) Immunostainings for Ins (green) and Isl-proteins (red) in the pancreatic region of control (A), isl1 mutant
(B), and isl1 mutant/MOisl2a injected embryos (C) at 48 hpf. (D) Quantiﬁcation of ins mRNA positive cells and examples of corresponding in situ stains for ins mRNA in isl1
mutants (E, G), and in isl1 mutant, MOisl2a injected embryos (F, H) at 30 hpf (E, F) and 72 hpf (G, H). Bars show meanþSEM.
A. Wilﬁnger et al. / Developmental Biology 378 (2013) 25–3730Conserved requirement for isl1 in endocrine cell maturation
To investigate if the reduction of endocrine hormones reﬂects a
loss of endocrine cells, we studied expression of isl1 mRNA, which
is stable in isl1sa0029 mutants. The clustering of isl1 expressing cells
into an islet and the size of these islets appeared indistinguishable
between mutants and control embryos at 48 hpf and 76 hpf
(Fig. 2A–F). Further, the numbers of isl1þ cells are similar in
control embryos (48 hpf: 42.871,1 (n¼8); 76 hpf: 56.872,4
(n¼9)) and isl1 mutants (48 hpf: 43.071,2 (n¼6); 76 hpf:
54.571.67 (n¼7)), suggesting that in isl1 mutants endocrine cells
are speciﬁed to adopt an endocrine fate, but fail to differentiate or
mature into hormone producing cells. Consistent with this notion,
we also ﬁnd that the endocrine progenitor marker pax6b is
expressed in similar numbers in control (38.671.1, n¼10) and in
isl1 mutants (39.870.7, n¼10) at 24 hpf (Fig. 2G, H, and Table. S2)
and in a comparable domain at 76 hpf (Fig. 2I and J).
Next, we asked if the conserved requirement of isl1 in endo-
crine differentiation is also associated with a conserved molecular
function. Whole mount expression analyses of 24 hpf and 48 hpf
embryos show that one of the few known pancreatic isl1 targets in
mouse, the transcription factor arx, is selectively lost in the
pancreas of isl1 mutant zebraﬁsh embyros (Fig. 2K–P). For quanti-
tative analyses of islet speciﬁc expression levels in 96 hpf embryos,
we performed qPCR analyses on pools of 25–30 isolated pancreata.
Using the relative expression levels of ins obtainted for 96 hpf
whole embryonic RNA (Fig. 1N) for islet-speciﬁc normalization ofthese data, we found a 7-fold reduction of pancreatic arx expres-
sion in mutants. Using the same normalization approach we also
determined expression level of additional transcription factors
with an islet-restricted expression in the pancreas. In agreement
with our whole mount expression studies, no differences were
found for the expression of endocrine progenitor markers includ-
ing pax6b, isl1 neuroD and mnx1, while expression of ins, gcga and
sst2 were strongly reduced (Fig. 2Q). These data suggest a
conserved molecular function of isl1 in endocrine cell maturation.
Overlapping expression of isl1, isl2a and isl2b in
pancreas mesenchyme
Due to the incomplete loss of endocrine hormones in isl1
mutant ﬁsh as compared to the complete loss of these hormones
in early Isl1 mouse mutants, we reasoned that other factors might
compensate for the loss of isl1 in ﬁsh. Promising candidates are
Isl2 proteins and in particular Isl2a which was shown earlier to be
able to compensate for Isl1 function during motoneuron differ-
entiation in zebraﬁsh (Hutchinson and Eisen, 2006). To gain
insight into possible interactions between isl factors in endocrine
differentiation, we analyzed pancreatic expression of isl2a and
isl2b mRNA and protein and we performed functional studies
using antisense morpholinos. We found that both isl2 genes are
expressed in the pancreatic region between 24 and 72 hpf. Double
stains for islet mRNAs and for endocrine-speciﬁc GFP in neuroD:
GFP transgenics revealed that only isl1 is expressed in endocrine
Fig. 5. Overlapping activities of three isl-genes in exocrine tissue formation. (A, B) Pancreatic ptf1/p48 mRNA expression is similar in control (A) and isl1−/−þMOisl2a/2b
embryos (B) at 48 hpf. (C, D) Differently, pancreatic mnr2a mRNA expression is reduced in isl1−/−þMOisl2a/2b embryos as compared to control embryos. (E, G) pdx1 mRNA
expression at 80 hpf reveals a similar morphology of the extrapancreatic duct (arrow) in control and isl1−/−þMOisl2a/2b embryos. Note the reduced gut speciﬁc pdx1 signals
(asterisk) in the isl-depleted embryos. (G, H) trypsin mRNA expressing in exocrine tissue of a control embryo (G) and in an isl1−/−þMOisl2a/2b embryos (G) at 76 hpf.
(I) Quantitative analyses on the length of trypsin mRNA expression domain in control and triple isl gene deﬁcient embryos at 76 hpf. Embryos are shown from ventral with
anterior to the left (A–F) or dorsal with anterior to the left (G, H). P-values for signiﬁcant changes are indicated. (J) qPCR analysis for mRNA expression levels of trypsin and
ela3l in 96 hpf old whole embryos, normalized to EF1α. Coloring of the bars corresponds to the same genotypes presented in (I). Bars show meanþSEM.
A. Wilﬁnger et al. / Developmental Biology 378 (2013) 25–37 31cells while all three isl-genes are expressed in overlapping, but
slightly different patterns in the pancreatic mesenchyme (Fig. 3).
To further conﬁrm this regulation, we performed immunostain-
ings with a pan-Isl antibody along with an anti-Ins antibody tomark β-cells. Control embryos showed robust anti-Isl signal in the
pancreatic islet and a slightly weaker signal in the pancreatic
mesenchyme. Consistent with an Isl1 independent regulation of
isl2 genes only in pancreatic mesenchyme, loss of isl1 in the
Fig. 6. Formation of pancreatic mesenchyme is independent of isl gene function. Neither the loss of all three isl-genes nor absence of vascularization in clochemutants results
in a loss of fgf10, fgf24 or meis3. Expression patterns of meis3 (A–D), fgf10 (E–H) and fgf24 (I–L) in pancreatic mesenchyme of control embryos (B, F, J), isl1/2a/2b depleted
embryos (C, G, K) and cloche mutants (D, H, L). All images are ventral with the exception of A, E, I which are dorsal views. Anterior is to the left. Insets in A, E, I mark the
position of the higher resolution images shown on the right side.
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signal but not the signal in pancreatic mesenchyme (Fig. 4B).
The lack of islet antibody staining in Insþ cells of isl1 mutants
argues against a cell autonomous role of Isl2 proteins in early
endocrine cell differentiation. To exclude that low levels of Isl2
might have a compensatory function in endocrine cell formation,
we analyzed ins expression in isl1 mutant embryos injected
with isl2a translation-blocking MO. Interestingly, immunostain-
ings showed that injection of isl2a-MO was sufﬁcient to entirely
eliminate pancreatic anti-islet signals in isl1 mutants. While this
suggests efﬁcient knockdown of all remaining Islet proteins by the
isl2a morpholino injection, it could also indicate that the levels of
Isl2b expression in these embryos is below the detection limit or
that Isl2b proteins are not recognized by the antibody (Fig. 4C). In
the case of redundant activities, we expected to see a further
reduction or even complete loss of endocrine cells in isl1 mutants/
isl2a morphants. In contrast, no differences in the number of ins
expressing cells at 30 hpf and 72 hpf (Fig. 4D–H and Table. S3)
could be detected between uninjected isl1 mutants and isl2a MO
injected mutants (Fig. 4D). In conclusion, this suggests that
among the three isl-genes in zebraﬁsh only isl1 has activity in
endocrine cells, while all three genes are expressed in the
pancreatic mesenchyme.
Interaction of isl1 and isl2 genes during exocrine pancreas
development
A previous study in zebraﬁsh reported that injection of an isl1
translation-blocking morpholino caused a concentration depen-
dent reduction of the exocrine pancreas (Wan et al., 2006). As we
have shown that there is overlapping expression of three isl-genes
in pancreatic mesenchyme, we hypothesized that isl1 and isl2
genes could have overlapping functions in ventral pancreatic bud
formation. To test this, we analyzed pancreas formation in isl1mutant embryos that were further injected with isl2a/isl2b-MO to
generate isl1/2a/2b triple negative embryos. Analysis of early
ventral bud markers at 48 hpf revealed a similar expression
pattern for ptf1/p48 in control and isl1/2 depleted embryos and a
reduced mnr2a expression domain in the isl1/2 depleted embryos.
The data suggest that Isl proteins are dispensable for initiation
ventral bud formation (Fig. 5A and B), but might be involved in
ventral bud expansion (Fig. 5C and D). Analyses of isl1/2 depleted
embryos at 76–80 hpf revealed normal formation of the pdx1þ
extra-pancreatic duct (Fig. 5E and F), but a strong reduction of the
exocrine cell marker trypsin (Fig. 5G and H, Fig. S4).
To address the question of whether isl-genes interact during
exocrine tissue formation, trypsin expression was also further
analyzed in embryos lacking individual isl-genes or a combination
of two isl-genes (Fig. S4). The stainings displayed a variable
reduction of trypsin expression, very similar to the phenotypes
described after injection of isl1 translation blocking MO (Wan
et al., 2006). For quantiﬁcation, we measured the maximum
distance from head to the tail of the trypsin expression domain
(Fig. S4, Table. S4). We found that loss of either isl1 or isl2a alone
results in a signiﬁcant shortening of the trypsin expression
domains by about 30% and that the shortening is further enhanced
to 47% in isl1/2a double-deﬁcient embryos (Fig. S4A–F and I). Isl2b
appears to have only minor functions, as the knockdown did not
signiﬁcantly reduce the trypsin domain in control or isl2a mor-
phants (Fig. S4C, D and I). However, isl2b morpholino injection did
cause a signiﬁcantly shorter trypsin expression when combined
with the loss of isl1 or isl1/2a function (Fig. S4G, H and I).
For further analysis, expression of trypsin and ela3l, a second
exocrine marker with a slightly later onset of expression (Wan
et al., 2006), were analyzed by qPCR in 96 hpf embryos. The data
conﬁrmed the strong reduction of trypsin in isl1 mutants and
revealed a loss of ela3l expression in these mutants (Fig. 5J). While
whole mount analyses of 96 hpf embryos conﬁrmed the reduction
Fig. 7. TUNEL and EdU assays on control and mutant embryos. (A–D) Confocal image projections of 30 hpf (AþB) and 48 hpf (CþD) old control and isl1 mutant embryos in
the tg[hb9:GFP] background after TUNEL labeling for apoptotic cells. The arrow highlights individual TUNELþ cells in the vicinity of the GFP labeled islet. No TUNELþ cells
were found within the pancreatic islet of control or mutant ﬁsh at all analyzed stages. (EþF) Confocal sections of 96 hpf embryos labeled for Ins (in red) and EdU (in blue).
Embryos were treated with EdU from 48 hpf to 96 hpf. Note that very few EdUþ cell are present within the islet (highlighted by yellow circle), while most of the nuclei in the
surrounding exocrine tissue are EdU-positive. All images show ventral view, anterior to the left. (G) Numbers of Insþ and Insþ/EdUþ cells in control and isl1 mutants.
(H) Percentage of EdUþ/Insþ cells in relation to the number of Insþ cells. Bars show meanþSEM.
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qPCR analyses show that knockdown of isl2-genes had only mild
and not statistically signiﬁcant effects on the expression levels of
trypsin and ela3l (Fig. 5J). In summary the data reveal interactions
between mesenchymal isl1 and isl2a/b in non-cell autonomous
regulation of exocrine pancreas growth and morphogenesis. The
strong reduction of trypsin and loss of ela3l in isl1 mutants but not
in isl2 morphants indicates a potential isl1-speciﬁc function in
exocrine tissue speciﬁcation or maturation.
Isl1 mutant mice lack two tissues with important non-cell
autonomous function during pancreas formation, the dorsal aorta
endothelium and the pancreatic mesenchyme (Ahlgren et al.,
1997; Lammert et al., 2003). While the dorsal aorta has been
shown to form normally in the isl1 mutant zebraﬁsh (de Pater
et al., 2009), it is still possible that defects in pancreatic mesench-
yme formation may account for the defects in exocrine tissueextension. Notably, the mesenchymal expression of isl1 mRNA
itself is unchanged in the isl1 embryos (Fig. 2C and D), indicating
that pancreatic mesenchyme is established in the mutants.
Analyses of the pancreatic mesenchyme markers meis3, fgf10 and
fgf24 (Manfroid et al., 2007) also revealed a similar expression in
control embryos and in embryos in which the activity of individual
or combinations of two or three islet genes has been disrupted
(Figs. 6 and S6). Finally we investigated the contribution of the
dorsal aortic endothelium to establishing pancreatic mesenchyme.
Analyses of cloche mutant embryos (clo−/−), which lack endothelial
cells (Stainier et al., 1995), revealed normal patterns of meis3, fgf10
and fgf24 (Fig. 6 D, H and L). Thus, neither isl-genes nor the aortic
endothelium appear to be required for the formation of pancreatic
mesenchyme or for the transcriptional regulation of the identiﬁed
mediators of exocrine expansion, fgf10 and fgf24 within this tissue
(Manfroid et al., 2007). This suggests that the requirement for
Fig. 8. Endocrine hormone expression in ﬁrst and second wave endocrine cells in control and isl1 mutant embryos. Single plane views from confocal images of the primary
islets from control (A–C) and isl1 mutants (D–E). Embyros were injected with H2B-RFP (in red) encoding mRNA at the one cell stage and were immunostained (in green) for
Ins (A, D), Sst (B, E) and Gcg (C, F) at 96 hpf. Cells that left cell-cycle early in development show a red nuclear label due to the injecetion of H2B-RFP encoding mRNA at the one
cell stage. Arrowheads indicate examples of hormoneþ/RFPþ cells (refered to as DBCs), while arrows indicates examples of hormoneþ/RFP− cells (referred to as VBCs). (G, H)
Quantiﬁcation of hormoneþ DBCs (G) and VBCs (H) in control (black bars) and isl1 mutant embryos (white bars). Note that isl1 mutants show signiﬁcantly reduced numbers
for all DBCs, while only the number of Sst expressing VBCs cells is signiﬁcantly reduced. Bars show meanþSEM.
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mouse and zebraﬁsh, even though the non-cell autonomous
function of isl-genes in exocrine pancreas extension appears to
be conserved between these organisms.
Distinct function of isl1 in ﬁrst and second wave endocrine cells
In normal pancreas development, the endocrine cell mass
increases after 36 hpf as the result of differentiation and prolifera-
tion of late forming ventral bud derived endocrine cells (Field
et al., 2003; Hesselson et al., 2009; Moro et al., 2009). Consistent
with published data, we ﬁnd that the control embryos showed
increasing numbers of hormone expressing cells types between
24–96 hpf (Figs. 1, S2 and Table S1). In isl1 mutants, we ﬁnd that
the number of Sst expressing cells remains unaltered, while Ins
and Gcg expressing cells show an increase in numbers similar to
that of the control embryos (Fig. 1M). In order to determine
possible contribution of isl1 to cell death or proliferation, mutantswere analyzed for the presence of apoptotic cell nuclei by TUNEL
stains and for mitosis by DNA-incorporation assays using the
thymidine analog EdU. TUNEL stains of hb9:GFP transgenic
embryos at 30 hpf and 48 hpf revealed similar results for control
and isl1 mutant embryos, with some rare TUNEL signals in the
environment of the GFP labeled islets but no signals within the
islets (Fig.7A–D). For the EdU incorporation assays, control animals
and isl1 mutants were injected with EdU at 48 hpf and analyzed at
96 hpf. In agreement with previous reports (Hesselson et al., 2009;
Kimmel et al., 2011; Moro et al., 2009), embryos showed EdU
incorporation into most of the exocrine cells but in only very few
endocrine cells. While isl1 mutants have less Insþ/EdUþ cells than
control embryos (Fig. 7G), the proportion of Insþ/EdUþ cells is
similar for both genotypes (Fig. 7H). This suggests that loss of isl1
has no major effect on endocrine cell proliferation or survival.
The age-dependent increase of α- and β-cell number in mutants
could result from a delayed differentiation of early forming α- and
β-cells, or alternatively from the normal onset of hormone
A. Wilﬁnger et al. / Developmental Biology 378 (2013) 25–37 35expression in late forming second wave cells. In order to distin-
guish between these options, we used a recently described cell
tracking approach that allows differential labeling of early born
ﬁrst- and later born second-wave cells (Brennand et al., 2007;
Hesselson et al., 2009). In these experiments, embryos are injected
with mRNA encoding the long-living ﬂuorescent histone variant
H2B-mRFP1. As the H2B-mRFP1 protein is equally distributed to
daughter cells during mitosis, ﬂuorescent intensities per nucleus
exponentially decrease with every cell division. DBCs leave the
cell-cycle early in development and therefore remain high levels of
H2B-mRFP1, even later in development. The VBCs undergo more
rounds of cell division and remain proliferative even after onset of
hormone expression, which leads to the dilution of RFP label
below level of detection (Hesselson et al., 2009). In the case of
normal forming second-wave α- and β-cells, we expected to ﬁnd
RFPþ as well as RFP− α- and β-cells. As the early forming Gcg-cells
are virtually absent in isl1 mutants, most ‘second wave-derived’
Gcg-expressing cells at later stages should be RFP−. By contrast, as
the number of Sst-expressing cells remains constant between 28–
76 hpf we expect most of the Sst-expressing cells to be RFPþ in
older embryos. To address this question, we injected H2B-mRFP1
mRNA into one-cell stage eggs and analyzed RFP expression in
endocrine cells at 96 hpf. As expected, Insþ/RFPþ and Insþ/RFP−
cells were found in mutant ﬁsh, while most Sst expressing cells
were RFPþ . In contrast to our expectations, we also found a few
Gcgþ/RFPþ cells, possibly indicating a delayed onset of Gcg
expression in isl1 mutant ﬁrst wave α-cells (Fig. 8 and Table S6).
To determine if hormoneþ second wave cells are formed in normal
numbers, we counted hormoneþ/RFP− endocrine cells in control
and isl1 mutant embryos. While the total number of hormoneþ/
RFP− second wave cells is reduced from 32 RFP− cells in control
down to 18 RFP− cells in isl1 mutants, these embryos show no
signiﬁcant difference in the amount of ventral bud derived Insþ/
RFP− and Gcgþ/RFP− cells. This suggests that differentiation of Ins-
and Gcg-expressing cells from the later-arising VBCs is not affected
by the loss of isl1. However, there is a reduction of late forming Sst-
expressing cells. These data show a different requirement for isl1
in early versus late forming endocrine cells.Discussion
Here, we present a genetic analysis of pancreatic isl-gene
function in zebraﬁsh. We show that isl1 is co-expressed with isl2a
and isl2b in pancreatic mesenchyme, and that all three isl-genes
have additive functions in exocrine pancreas expansion. Further,
we show that isl1 alone is active in endocrine cells, we reveal cell
type speciﬁc requirements for isl1 in endocrine cell maturation
and we show that these requirements are different in ﬁrst and
second wave endocrine cells.
Interactions of isl1 and isl2 genes in exocrine pancreas formation
Various studies in mouse and chicken have demonstrated that
signal exchange between pancreatic mesenchyme and pre-
pancreatic endoderm is a major regulator of early pancreas
morphogenesis and exocrine tissue induction (Gittes, 2009). While
the molecular nature of the involved signals is still not completely
understood, explant studies performed as part of the Isl1 mouse
knock out analyses placed Isl1 upstream of a mesenchymal signal
that regulates exocrine pancreas formation (Ahlgren et al., 1997).
Similarly, the strong reduction of trypsin in isl-depleted zebraﬁsh
embryos argues for a role for zebraﬁsh isl-genes in regulating an
exocrine pancreas inducing or expanding factor. Interestingly, in
mouse, loss of Isl1 alone is sufﬁcient to prevent activation of
exocrine markers in dorsal pancreatic bud derived tissues. Bycontrast, we ﬁnd that in zebraﬁsh pancreatic mesenchyme, three
isl-genes contribute in an additive manner to exocrine expansion.
One possibility is that Isl proteins have redundant activities, which
is also supported by the observation that isl2a can functionally
compensate for loss of isl1 in motoneuron speciﬁcation
(Hutchinson and Eisen, 2006). While pancreatic isl2 functions
have not been addressed in mammals, it is interesting to note
that isl2 expression has been reported for the human pancreas (Li
et al., 2007).
In this work, we show that in Isl protein-depleted embryos,
mRNA expression of meis3, fgf10 and fgf24 is not signiﬁcantly
reduced in the pancreatic mesenchyme. This suggests that isl-
genes in ﬁsh are not required for the formation of pancreatic
mesoderm, as is the case in mouse. Notably, in the Isl1 mutant
mouse, the loss of dorsal pancreatic mesenchyme is associated
with a loss of the dorsal aorta by apoptosis (Ahlgren et al., 1997).
The dorsal aorta in mouse has direct contact with the pancreatic
mesenchyme and the lack of endothelial cells prevents the
formation of the pancreatic mesenchyme (Jacquemin et al.,
2006). While the presence of the dorsal aorta in isl1 mutant
zebraﬁsh (de Pater et al., 2009) might explain the weaker pheno-
type in the ﬁsh, we also show that a loss of dorsal aorta in cloche
mutants has no effect on the expression of pancreatic mesench-
yme markers. In agreement with a previous report showing
normal expression of trypsin in cloche mutants (Field et al.,
2003), our results suggest that tissues other than the dorsal aorta
regulate pancreatic mesenchyme induction in ﬁsh. Consistent with
this notion, it was shown that between 26 and 29 hpf, fgf10 and
fgf24 expressed in the endoderm induce pancreatic mesenchyme
identity within the lateral plate mesoderm and controls isl1 and
meis3 expression in this mesenchyme (Manfroid et al., 2007). After
29 hpf, Fgfs expressed in the pancreatic mesenchyme are required
for exocrine tissue expansion and correct speciﬁcation of the
hepatopancreatic duct system (Dong et al., 2007; Manfroid et al.,
2007). The normal presence of fgf10 and fgf24 mRNA in the
mesenchyme of isl-depleted embryos in combination with the
reduced size of the exocrine pancreas in the isl1 mutants suggests
that Isl proteins must regulate other paracrine factors and that Isl
proteins either alone or in parallel to Fgf10/24 promote exocrine
tissue expansion.
Isl functions in endocrine cell differentiation
In amniotes, ﬁrst wave endocrine cells can be distinguished
from second wave cells by several features including a reduced
spectrum of cell types and a lack of cell renewal in ﬁrst wave cells.
Studies in zebraﬁsh only recently showed that production of ﬁrst
and second wave cells, and the lack of self-renewal capacity, is
evolutionary conserved between mammals and ﬁsh (Hesselson
et al., 2009). In zebraﬁsh, the ﬁrst wave cells display the same
spectrum of hormone expressing cell types as are found in second
wave cells. The role of ﬁrst wave cells and the reason why
zebraﬁsh embryos establish the different types of ﬁrst wave cells
is currently not known. One possible explanation is a requirement
for a mother-independent glucose regulation that is happening
already in the ﬁsh embryo (Eames et al., 2010; Jurczyk et al., 2011).
Such a function implies a similar physiological role of ﬁrst and
second wave cells and possibly a similar molecular regulation of
differentiation. However, we ﬁnd that loss of isl1 has different
effects on ﬁrst and second wave cell maturation. This underscores
the dissimilarity between ﬁrst and second wave cells, and suggests
that studies on ﬁrst wave cells may provide only limited informa-
tion relevant to the behavior of the cells of the mature organ,
namely the second wave cells.
Most surprisingly, we found that loss of isl1 had no statistically
signiﬁcant effect on the number of Ins- and Gcg-expressing second
A. Wilﬁnger et al. / Developmental Biology 378 (2013) 25–3736wave cells. As these hormones are strongly reduced in the
pancreas-speciﬁc Isl1mouse knock-out (Du et al., 2009), this could
indicate that isl1 functions are not only different in ﬁrst and
second wave zebraﬁsh cells, but also with respect to their function
in second wave cell maturation, proliferation and survival in ﬁsh
versus mouse. Mutant zebraﬁsh start to develop obvious defects
after 4 dpf, e.g. in blood circulation, that affect the general ﬁtness
of the embryo. Therefore our studies were restricted to the ﬁrst 4–
5 days of development, during which time only few second wave
cells in the vicinity of the primary islet are established. Additional
experiments that overcome late embryonic lethality of isl1 ﬁsh
mutants will be required to address possible later functions. Our
studies revealed no obvious differences in embryonic β-cell survi-
val and proliferation between control and isl1 mutants. However,
only second wave cells are supposed to be proliferatively active
(Hesselson et al., 2009). As our data suggest normal formation of
second wave α- and β-cells, the reduced number of Insþ/EdUþ
cells in isl1 mutants could indicate reduced β-cell proliferation.
Furthermore, expression of endocrine hormones is initiated early
during endocrine cell maturation and the observed presence of
hormones does not exclude defects during later steps of matura-
tion. Molecular markers that are used to distinguish later matura-
tion stages in mammalian β-cells are currently not established in
ﬁsh. To further dissect the role of isl1, it will be important to learn
more about the targets of Isl proteins.
Results from transcriptome analyses of puriﬁed neuronal cells,
and tissues isolated from control and Isl1 mutant animals, pro-
vided hints for potential Isl1 targets in sensory cells (Sun et al.,
2008). Similar to the expression in endocrine cells, Isl1 is also
active in differentiating and mature neuronal cells. It is therefore
interesting to note that the transcriptome comparison links Isl1
function to the molecular machineries driving cell differentiation
as well as to mature cell function. More recently, major progress
has also been made in identifying additional pancreatic Isl1
targets, including transcription factors such as MafA and arx (Du
et al., 2009; Liu et al., 2011) as well as known cell-cycle regulators
such as Cyclin D1 or c-Myc (Guo et al., 2011). The loss of pancreas
speciﬁc arx expression not only in mouse but also in zebraﬁsh isl1
mutants provides promising evidence for a conserved molecular
function for isl1 in endocrine cell maturation.Conclusion
Pancreatic expression of vertebrate Isl1 genes is highly con-
served in pancreatic mesenchyme and in post-mitotic endocrine
cells. Our genetic analysis in zebraﬁsh is the ﬁrst that addresses
pancreatic isl1 functions outside the mouse. Our analyses reveal a
novel interaction between isl1 and isl2 genes in exocrine pancreas
expansion and they implicate cell type speciﬁc requirements for
isl1 in endocrine cell maturation. While our data suggest that the
conserved expression correlates with conserved requirements for
islet genes in non-cell autonomous exocrine pancreas expansion
and cell-autonomous endocrine cell maturation, they also high-
light species-speciﬁc differences in pancreatic isl1 functions. In
particular we ﬁnd differences with respect to the requirement for
isl-genes in pancreatic mesenchyme formation, the induction of
hormone expression in ﬁrst wave cells, and the cell type speciﬁc
requirements in endocrine cells.Acknowledgments
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